GSK plc
GLAXF
$26.00
$0.532.08%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.29% | 59.54% | 3,696.29% | 30.27% | 54.21% |
| Total Depreciation and Amortization | -40.94% | -423.43% | -19.59% | 92.06% | 48.89% |
| Total Amortization of Deferred Charges | -- | 8.28% | -- | -- | -- |
| Total Other Non-Cash Items | 104.70% | -14.02% | 89.97% | 786.34% | -56.60% |
| Change in Net Operating Assets | -44.15% | 188.24% | -130.51% | -76.66% | -151.66% |
| Cash from Operations | 4.62% | 1.58% | 6.89% | 99.42% | 18.71% |
| Capital Expenditure | -11.55% | -9.39% | -5.66% | 10.24% | 16.70% |
| Sale of Property, Plant, and Equipment | 2,734.51% | -77.87% | 418.10% | 164.73% | -0.67% |
| Cash Acquisitions | -84.08% | 31.30% | -22,178.29% | 90.37% | -10.47% |
| Divestitures | 25,820.50% | 120.77% | 134.54% | -323.57% | 66.89% |
| Other Investing Activities | 13.96% | 39.27% | 9.70% | -132.72% | -116.05% |
| Cash from Investing | -34.53% | 13.41% | -117.02% | -185.95% | -662.59% |
| Total Debt Issued | -42.13% | -58.84% | -- | -- | -- |
| Total Debt Repaid | 66.20% | 93.15% | 89.74% | -163.76% | 43.16% |
| Issuance of Common Stock | -33.33% | -- | -100.00% | 100.00% | -33.33% |
| Repurchase of Common Stock | -31.98% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.30% | -9.62% | -10.05% | -6.54% | -7.02% |
| Other Financing Activities | 166.67% | -3.35% | -724.00% | 31.75% | -20.00% |
| Cash from Financing | -66.72% | -5.58% | -9.89% | -58.57% | 180.40% |
| Foreign Exchange rate Adjustments | 119.09% | -708.27% | 279.81% | -244.15% | 42.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -106.31% | 24.07% | -492.92% | -437.33% | 411.95% |